Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P50148: Variant p.Arg183Gln

Guanine nucleotide-binding protein G(q) subunit alpha
Gene: GNAQ
Feedback?
Variant information Variant position: help 183 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Glutamine (Q) at position 183 (R183Q, p.Arg183Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SWS; found as somatic mosaic mutation in CMC; also found in melanocytomas sample; somatic mutation; shows significant activation of EPHB2 compared to control. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 183 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 359 The length of the canonical sequence.
Location on the sequence: help DLDRVADPAYLPTQQDVLRV R VPTTGIIEYPFDLQSVIFRM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DLDRVADPAYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

                              DLDRVADPAYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

Mouse                         DLDRVADPSYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

Rat                           DLDRVADPSYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

Pig                           DLDRVADPAYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

Xenopus laevis                DLDRIATHGYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRM

Drosophila                    DLARIEQADYLPTEQDILRARVPTTGILEYPFDLDGIVFRM
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 359 Guanine nucleotide-binding protein G(q) subunit alpha
Domain 38 – 359 G-alpha
Region 178 – 186 G2 motif
Binding site 180 – 180
Binding site 181 – 181
Binding site 183 – 183
Binding site 186 – 186



Literature citations
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
Shirley M.D.; Tang H.; Gallione C.J.; Baugher J.D.; Frelin L.P.; Cohen B.; North P.E.; Marchuk D.A.; Comi A.M.; Pevsner J.;
N. Engl. J. Med. 368:1971-1979(2013)
Cited for: INVOLVEMENT IN CMC; VARIANT SWS GLN-183; CHARACTERIZATION OF VARIANT SWS GLN-183; GNAQ and GNA11 mutations in melanocytomas of the central nervous system.
Murali R.; Wiesner T.; Rosenblum M.K.; Bastian B.C.;
Acta Neuropathol. 123:457-459(2012)
Cited for: VARIANT GLN-183;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.